Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 6/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4661689 | 0.80 | — | — | |
| SCHEMBL24130619 | 0.78 | ALDH1A1 (0.38) | ALDH1A1NFKB1KDM4EMAPTTHRB | |
| SCHEMBL3392039 | 0.71 | KDM4E (0.50) | ALDH1A1NFKB1KDM4EMAPTTHRB | |
| SCHEMBL13692 | 0.71 | — | — | |
| SCHEMBL14157901 | 0.71 | TRPV1 (0.46) | ALDH1A1NFKB1KDM4EMAPTTHRB | |
| SCHEMBL82871 | 0.69 | — | — | |
| SCHEMBL149183 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL6489775 | 0.69 | — | — | |
| SCHEMBL7051108 | 0.69 | ALDH1A1 (0.41) | ALDH1A1MAPTSMN1; SMN2KMT2A | |
| SCHEMBL4278579 | 0.67 | KDM4E (0.44) | ALDH1A1NFKB1KDM4EMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0762901-B9 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | CIS BIO INT (FR) | 2007-01-17 | — | — | EP | claimed |
| EP-0762901-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | BERLEX INC (US) | 2006-04-19 | — | — | EP | claimed |
| EP-1583565-A1 | ENHANCED SCINTIGRAPHIC IMAGING AGENTS FOR IMAGING OF INFECTION AND INFLAMMATION | Schering AG (DE) | 2005-10-12 | — | — | EP | claimed |
| US-20050002861-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-01-06 | — | — | US | claimed |
| EP-0775160-B1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATIDE INC (US) | 2004-08-18 | — | — | EP | claimed |
| WO-2004060409-A1 | ENHANCED SCINTIGRAPHIC IMAGING AGENTS FOR IMAGING OF INFECTION AND INFLAMMATION | SCHERING AG (DE) | 2004-07-22 | — | — | WO | claimed |
| EP-1437145-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | Schering AG (DE) | 2004-07-14 | — | — | EP | claimed |
| EP-0804481-B1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATIDE INC (US) | 2003-04-16 | — | — | EP | claimed |
| US-6241965-B1 | MEDICAL DIAGNOSTIC AND ANTITUMOR AGENTS | DIATIDE, INC. | 2001-06-05 | — | — | US | claimed |
| US-6074627-A | STABLE COMPLEX | DIATIDE, INC. (US) | 2000-06-13 | — | — | US | claimed |
| US-6019958-A | POLYBASIC COMPOUND HAVING A MOLECULAR WEIGHT FROM ABOUT 500 DALTONS TO ABOUT 15,000 DALTONS WITH A TECHNETIUM-99M BINDING MOIETY COVALENTLY LINKED TO THE COMPOUND; AND A POLYSULFATED GLYCAN HAVING A MOLECULAR WEIGHT OF AT LEAST ABOUT 1,000 | DIATIDE, INC. (US) | 2000-02-01 | — | — | US | claimed |
| US-5997844-A | Technetium-99m labeled peptides for imaging | DIATIDE, INC. (US) | 1999-12-07 | — | — | US | claimed |
| EP-0702570-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION | DIATIDE INC (US) | 1999-08-04 | — | — | EP | claimed |
| US-5932189-A | RADIOTHERAPY, RADIODIAGNOSIS PEPTIDES | DIATECH, INC. (US) | 1999-08-03 | — | — | US | claimed |
| US-5830856-A | RADIOLABELED SCINTIGRAPHIC IMAGING | DIATIDE, INC. (US) | 1998-11-03 | — | — | US | claimed |
| EP-0772460-A1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1997-05-14 | — | — | EP | claimed |
| WO-1995033496-A1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1995-12-14 | — | — | WO | claimed |
| WO-1995003330-A1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATECH, INC. (US) | 1995-02-02 | — | — | WO | claimed |
| WO-1995000553-A1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1995-01-05 | — | — | WO | claimed |
| US-7238340-B1 | Monoamine, diamide, thiol-containing metal chelating agents | CIS BIO INTERNATIONAL (FR) | 2007-07-03 | — | — | US | disclosed |
| EP-0762901-B9 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | CIS BIO INT (FR) | 2007-01-17 | — | — | EP | disclosed |
| EP-1092726-B1 | Radioactively-labeled somatostatin derived peptides for imaging and therapeutics uses | DIATIDE INC (US) | 2006-08-23 | — | — | EP | disclosed |
| EP-0762901-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | BERLEX INC (US) | 2006-04-19 | — | — | EP | disclosed |
| US-20050002861-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-01-06 | — | — | US | disclosed |
| EP-0775160-B1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATIDE INC (US) | 2004-08-18 | — | — | EP | disclosed |
| EP-1437145-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | Schering AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| EP-0804252-B1 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATIDE INC (US) | 2003-08-13 | — | — | EP | disclosed |
| EP-0804481-B1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATIDE INC (US) | 2003-04-16 | — | — | EP | disclosed |
| US-6509001-B1 | Peptide covalently linked to radioactive metal or iodine chelator; diagnostic and therapeutic modalities against cancer; lung and ovarian adenocarcinoma, breast cancers and lymphomas | DIATIDE, INC. | 2003-01-21 | — | — | US | disclosed |
| US-6479032-B1 | Calcitonin receptor binding reagents | DIATIDE, INC. | 2002-11-12 | — | — | US | disclosed |
| US-6241965-B1 | MEDICAL DIAGNOSTIC AND ANTITUMOR AGENTS | DIATIDE, INC. | 2001-06-05 | — | — | US | disclosed |
| EP-1099707-A2 | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses | Diatide, Inc. (US) | 2001-05-16 | — | — | EP | disclosed |
| EP-1092726-A2 | Radioactively-labeled somatostatin derived peptides for imaging and therapeutics uses | Diatide, Inc. (US) | 2001-04-18 | — | — | EP | disclosed |
| EP-0720621-B1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATIDE INC (US) | 2001-02-07 | — | — | EP | disclosed |
| US-6086850-A | SYNTHETIC CALCITONIN RECEPTOR-BINDING COMPOUND OF GIVEN MOLECULAR WEIGHT COVALENTLY LINKED TO A RADIOMETAL CHELATOR TO FORM A REAGENT HAVING A BINDING AFFINITY FOR A CALCITONIN RECEPTOR GREATER OR EQUAL TO RADIOIODINATED NATIVE CALCITONIN | DIATIDE, INC. (US) | 2000-07-11 | — | — | US | disclosed |
| US-6083480-A | RADIOTHERAPEUTIC REAGENTS AND PEPTIDES, RADIODIAGNOSTIC REAGENTS AND PEPTIDES | DIATIDE, INC. (US) | 2000-07-04 | — | — | US | disclosed |
| US-6074627-A | STABLE COMPLEX | DIATIDE, INC. (US) | 2000-06-13 | — | — | US | disclosed |
| US-6051206-A | CYCLIC PEPTIDE DERIVATIVES; RADIODIAGNOSIS; IMAGING | DIATIDE, INC (US) | 2000-04-18 | — | — | US | disclosed |
| US-6022520-A | ADMINISTERING A DIAGNOSTIC AMOUNT OF A RADIOLABELED REAGENT CAPABLE OF INHIBITING HUMAN PLATELET AGGREGATION COMPRISING RADIOLABEL COMPLEXING MOIETY AND A PLATELET GLYCOPROTEIN IIB/IIIA-BINDING COMPOUND COVALENTLY LINKED TO THE MOIETY | DIATIDE, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-6022857-A | Radiolabeled compounds for thrombus imaging | DIATIDE, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-6019958-A | POLYBASIC COMPOUND HAVING A MOLECULAR WEIGHT FROM ABOUT 500 DALTONS TO ABOUT 15,000 DALTONS WITH A TECHNETIUM-99M BINDING MOIETY COVALENTLY LINKED TO THE COMPOUND; AND A POLYSULFATED GLYCAN HAVING A MOLECULAR WEIGHT OF AT LEAST ABOUT 1,000 | DIATIDE, INC. (US) | 2000-02-01 | — | — | US | disclosed |
| US-6007792-A | CHELATE COMPOUNDS LABELED WITH TECHNETIUM-99M, RHENIUM-186, OR RHENIUM-188; TUMOR IMAGING | DIATIDE, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| US-5997844-A | Technetium-99m labeled peptides for imaging | DIATIDE, INC. (US) | 1999-12-07 | — | — | US | disclosed |
| US-5955426-A | SUCH PEPTIDES RADIOLABELED WITH A RADIOSIOTOPE, AS WELL AS METHODS FOR USING SUCH PEPTIDES FOR RADIODIAGNOSTIC AND RADIOTHERAPEUTIC PURPOSES | DIATIDE, INC. (US) | 1999-09-21 | — | — | US | disclosed |
| EP-0702570-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION | DIATIDE INC (US) | 1999-08-04 | — | — | EP | disclosed |
| US-5932189-A | RADIOTHERAPY, RADIODIAGNOSIS PEPTIDES | DIATECH, INC. (US) | 1999-08-03 | — | — | US | disclosed |
| US-5849261-A | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy | DIATIDE, INC. (US) | 1998-12-15 | — | — | US | disclosed |
| US-5830856-A | RADIOLABELED SCINTIGRAPHIC IMAGING | DIATIDE, INC. (US) | 1998-11-03 | — | — | US | disclosed |
| EP-0804252-A2 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATECH, INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| EP-0804481-A1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | Diatide, Inc. (US) | 1997-11-05 | — | — | EP | disclosed |
| EP-0772460-A1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1995033497-A1 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATECH, INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995033496-A1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995003330-A1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATECH, INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995000553-A1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1995-01-05 | — | — | WO | disclosed |
| WO-1995000553-A1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050002861-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | SIGLEC7, CD209, SIGLEC9 | ALDH1A1 4795/4885NFKB1 396/4885KDM4E 4063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.